Furthermore, MS-derived Akkermansia was found to improve experimental autoimmune encephalomyelitis via lowering RORγt+ and IL-17-producing γδ T cells, indicating a potentially beneficial, compensatory response of the microbiome in MS (53). Here, IL17A is linked to experimental autoimmune encephalomyelitis.